REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,758.50
Bid: 1,758.50
Ask: 1,759.00
Change: 25.00 (1.44%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks gain ahead of central bank announcements

Thu, 04th Oct 2012 08:23

- Investors await BoE and ECB decisions, FOMC minutes- Tate & Lyle jumps after Credit Suisse upgrades- Halfords appoints new CEO after strong Q2European stock markets have opened with moderate gains ahead of what is likely to be a busy day on the economic front, with rate decisions due out from the Bank of England (BoE) and European Central Bank (ECB) later today, as well as the minutes of the latest Federal Reserve meeting.The BoE's Monetary Policy Committee (MPC) is set to reveal whether it has made any alterations to its key interest rate and asset purchase programme (also known as quantitative easing, or QE) at noon.The smart money is on there being no change, with the interest rate staying at 0.5% and the asset purchase (quantitative easing, or QE) pot staying at £375bn. However, some are expecting an increase in QE and a 25 basis point rate cut in November.The ECB is also expected to remain in 'wait-and-see' mode when it reveals its policy decision after midday. Analysts believe that the ECB will wait for Spain to make the next move considering that it already announced its bond purchase plan for ailing countries that request aid. The key interest rate currently stands at 0.75% after it was cut by 25 basis points early in the year. The deposit rate is at 0%. Analyst Craig Erlam from Alpari said: "There's been a lack of volatility in the markets in recent weeks as investors look beyond central banks to the governments for reassurance on the next step in the debt crisis. The uncertainty surrounding Spain has left investors unsure on how to position themselves as we approach near end. Given a lack of details out of the eurozone, there is a hope that the ECB will give us some valuable insight into this."Meanwhile, the Federal Open Market Committee (FOMC) minutes are also on the agenda for later. Analyst Moyeen Islam from Barclays Research said this morning that the minutes should provide more "granularity regarding what the Fed may judge to be a 'sustainable improvement' in the labour market that would underpin any decision to end the current open-ended commitment to asset purchases.FTSE 100: Tate & Lyle gains after broker upgradeSweeteners and food products group Tate & Lyle was the high riser in early trading after Credit Suisse raised its recommendation for the stock from 'neutral' to 'outperform'. The broker said: "There is no easy way to value Tate & Lyle, but it does seem to us to be a better business for all the changes we have seen and that this is not reflected in the share price (which is down 8% year to date versus a staples sector up 18%)."Evraz fell after acquiring an indirect controlling interest in OJSC Raspadskaya, one of Russia's largest producers of coking coal and a supplier to the Russian steel firm.Pharmaceuticals behemoth GlaxoSmithKline gained after saying its joint venture company, Shionogi-ViiV Healthcare, has completed an initial clinical registration package for dolutegravir, its treatment for HIV patients.Supermarket peers Tesco and Sainsbury were among the stocks in the red following their results and trading update yesterday, respectively. Exane BNP Paribas reduced its target price for Tesco this morning from 325p to 300p and reiterated its 'underperform' rating on the shares. FTSE 250: Halfords surges after impressive Q2, new CEO appointmentCar and bike parts retailer Halfords jumped after appointing a new Chief Executive Officer following the abrupt departure of David Wild in the summer, as it revealed that full-year profits would be at the top end of guidance after a strong second quarter.The company expects pre-tax profit to be in the region of £40-42m in the first half on the back of its second quarter performance and an acceleration of operating cost investment. The consensus estimate currently stands at just £35.8m. Fashion chain Ted Baker was in demand after saying that the reaction to its autumn/winter collections has been positive as it unveiled a solid first-half trading performance. FTSE 100 - RisersTate & Lyle (TATE) 691.50p +2.52%Standard Chartered (STAN) 1,421.00p +1.21%Prudential (PRU) 833.00p +1.09%Carnival (CCL) 2,336.00p +0.99%InterContinental Hotels Group (IHG) 1,655.00p +0.98%Barclays (BARC) 222.30p +0.93%International Consolidated Airlines Group SA (CDI) (IAG) 165.20p +0.92%Royal Bank of Scotland Group (RBS) 260.40p +0.89%Diageo (DGE) 1,795.00p +0.84%ITV (ITV) 91.95p +0.82%FTSE 100 - FallersEvraz (EVR) 239.60p -3.11%BHP Billiton (BLT) 1,929.00p -0.72%Tesco (TSCO) 325.75p -0.67%G4S (GFS) 266.50p -0.56%BG Group (BG.) 1,302.00p -0.53%BP (BP.) 436.85p -0.50%CRH (CRH) 1,183.00p -0.50%Johnson Matthey (JMAT) 2,406.00p -0.46%Amec (AMEC) 1,145.00p -0.43%British Land Co (BLND) 521.00p -0.29%FTSE 250 - RisersHalfords Group (HFD) 302.00p +13.53%Ted Baker (TED) 945.00p +3.45%Victrex (VCT) 1,372.00p +3.08%Stobart Group Ltd. (STOB) 115.40p +2.58%Ocado Group (OCDO) 67.70p +2.27%Rentokil Initial (RTO) 84.85p +2.23%Computacenter (CCC) 385.00p +2.18%Paragon Group Of Companies (PAG) 212.30p +2.07%Lonmin (LMI) 548.00p +2.05%FirstGroup (FGP) 197.30p +2.02%FTSE 250 - FallersRank Group (RNK) 146.90p -2.39%Hansteen Holdings (HSTN) 76.30p -2.18%Carpetright (CPR) 630.00p -2.10%IP Group (IPO) 118.60p -1.58%JD Sports Fashion (JD.) 709.00p -1.53%Dechra Pharmaceuticals (DPH) 583.00p -1.10%Bovis Homes Group (BVS) 495.20p -1.06%Kenmare Resources (KMR) 39.75p -1.00%Petra Diamonds Ltd.(DI) (PDL) 115.20p -0.95%Utilico Emerging Markets Ltd (DI) (UEM) 160.12p -0.86%BC
More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.